Myles Wolf

Insider Reports History

Entity
Individual
Location
C/O Akebia Therapeutics, Inc., 245 First Street, Cambridge, MA
Signature
/s / Carolyn Rucci, attorney-in-fact for Myles Wolf
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Myles Wolf:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Akebia Therapeutics, Inc. Director Common Stock 97.7K $123K $1.26 Jun 6, 2024 Direct
Akebia Therapeutics, Inc. Director Stock Option (Right to buy) 45K Jun 6, 2024 Direct

Insider Reports Filed by Myles Wolf

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AKBA Akebia Therapeutics, Inc. Jun 6, 2024 2 $0 4 Jun 10, 2024 Director
AKBA Akebia Therapeutics, Inc. Jun 6, 2023 2 $0 4 Jun 8, 2023 Director
AKBA Akebia Therapeutics, Inc. Jun 8, 2022 2 $0 4 Jun 9, 2022 Director
AKBA Akebia Therapeutics, Inc. Jun 2, 2021 2 $0 4 Jun 3, 2021 Director